within Pharmacolibrary.Drugs.ATC.J;

model J01CA10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 7.8 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 2000 / 1000000,
    adminCount     = 1,
    Vd             = 0.0184,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Mezlocillin is a broad-spectrum, semisynthetic penicillin antibiotic used primarily for the treatment of serious infections caused by susceptible Gram-negative and Gram-positive organisms, including Pseudomonas aeruginosa. It was previously widely used in hospitalized patients, particularly for intra-abdominal, urinary tract, and lower respiratory tract infections but is now largely withdrawn from the market and not approved in most countries today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Frimodt-Möller, N, Maigaard, S, Toothaker, RD, Bundtzen, RW, Brodey, MV, Craig, WA, Welling, PG, &amp; Madsen, PO (1980). Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function. <i>Antimicrobial agents and chemotherapy</i> 17(4) 599–607. DOI:<a href=&quot;https://doi.org/10.1128/AAC.17.4.599&quot;>10.1128/AAC.17.4.599</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6446877/&quot;>https://pubmed.ncbi.nlm.nih.gov/6446877</a></p></li><li><p>Jungbluth, GL, &amp; Jusko, WJ (1989). Dose-dependent pharmacokinetics of mezlocillin in rats. <i>Antimicrobial agents and chemotherapy</i> 33(6) 839–843. DOI:<a href=&quot;https://doi.org/10.1128/AAC.33.6.839&quot;>10.1128/AAC.33.6.839</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2764534/&quot;>https://pubmed.ncbi.nlm.nih.gov/2764534</a></p></li><li><p>Bergan, T (1978). Pharmacokinetics of mezlocillin in healthy volunteers. <i>Antimicrobial agents and chemotherapy</i> 14(6) 801–806. DOI:<a href=&quot;https://doi.org/10.1128/AAC.14.6.801&quot;>10.1128/AAC.14.6.801</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/742869/&quot;>https://pubmed.ncbi.nlm.nih.gov/742869</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01CA10;
